Andrew Stewart Plump sold $2.1M of Takeda Pharmaceutical Company Limited (TAK)

Executed Sep 2, disclosed Sep 4, 1 day later.

Value, as filed

$2.1M

116,191 sh × $18.49

Executed

Sep 2

the trade date, as filed

Disclosed

Sep 4

1 day after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

Andrew Stewart Plump President, R&D profile →

Andrew Stewart Plump (President, R&D) filed 3 Form 4 reports in the trailing twelve months (0 purchases, 3 sales), most often in Takeda Pharmaceutical Company Limited (TAK). The largest single filing was $2.8M of TAK (165,393 sh × $17.10, as filed), executed Aug 10.

The name

TAK

Takeda Pharmaceutical Company Limited TAK · Healthcare · 19 filings in 24 months ticker →

Healthcare · Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical pro…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Andrew Stewart Plump in TAK

TAKSALE Takeda Pharmaceutical Company Limited $363K
19,651 sh × $18.49
Exec Aug 19
Filed Aug 21 · 4:30 PM ET TAKSALE Takeda Pharmaceutical Company Limited $2.8M
165,393 sh × $17.10
Exec Aug 10
Filed Aug 12 · 9:50 PM ET